AOD-9604 vs Epithalon
A comprehensive, data-driven comparison of AOD-9604 (Advanced Obesity Drug) and Epithalon (Epitalon). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | AOD-9604 Advanced Obesity Drug, Tyr-hGH Fragment 176-191 | Epithalon Epitalon, Epithalone |
|---|---|---|
| FDA Status | Phase 2 (failed; reclassification pending) | Not submitted |
| Category | Weight Loss | Anti-Aging |
| Primary Use | Fat loss and metabolism enhancement | Anti-aging and longevity research |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $30 - $60/mo | $40 - $80/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 300mcg daily | 5-10mg per cycle (10-20 days, 2-3x per year) |
| Frequency | Daily | Cyclical |
| Mechanism | Modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis without affecting blood sugar or IGF-1 | Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend cellular lifespan |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Low | Emerging |
| Clinical Trial Phase | Phase 2 | N/A |
Key Differences
- 1AOD-9604 is generally more affordable ($30 - $60/mo) compared to Epithalon ($40 - $80/mo).
- 2AOD-9604 is dosed daily, while Epithalon is cyclical.
- 3AOD-9604 has low-quality evidence, while Epithalon has emerging-quality evidence.
- 4They belong to different categories: AOD-9604 (Weight Loss) vs Epithalon (Anti-Aging).
Which Is Better For...
AOD-9604
More budget-friendly option with lower monthly costs
Epithalon
More convenient dosing schedule (cyclical)
AOD-9604
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| AOD-9604 | $30 - $60/mo | Phase 2 (failed; reclassification pending) | Various research labs |
| Epithalon | $40 - $80/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
AOD-9604 works via Modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis. Epithalon works via Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend. They differ in FDA approval status, efficacy data, and cost.
AOD-9604 typically costs $30 - $60/mo, while Epithalon costs $40 - $80/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
AOD-9604 is not FDA-approved (Phase 2 (failed; reclassification pending)). Epithalon is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of AOD-9604 include Injection site reactions, Headache, Chest tightness (rare). Common side effects of Epithalon include Injection site reactions, Mild drowsiness, Vivid dreams. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
AOD-9604 is a modified peptide fragment of the C-terminus of human growth hormone (amino acids 176-191). It was designed to retain the fat-burning properties of HGH while avoiding effects on blood sug...
View Full AOD-9604 GuideEpithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched primarily in Russia for its potential anti-aging properties. The proposed mechanism involves activation of telomerase, an enzyme that...
View Full Epithalon GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between AOD-9604 and Epithalon should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.